MENU
JAN 23, 2024

The Future of Biomedicine: Reproducible Advanced Cell Systems and Translational Insights

More than 90% of therapeutic candidates fail to make it past phase III clinical trials, mainly due to the lack of adequate, advanced cell models to provide in-depth predictive insights that can translate into positive clinical outcomes. Comprehensive, 3D cell biological and stem cell-based models such as organoids and spheroids, more accurately mirror the diverse cellular ecosystem of complex tissues and provide invaluable insights into disease mechanisms, progression, and response to treatment.

This half-day event from Sartorius features two complementary, automated platforms that are revolutionizing the way advanced cell models are being created by introducing real-time live-cell analysis alongside automated cell selection and retrieval into drug discovery workflows.

Learn more about:

  • Challenges of organoid cultures and assays
  • Tips for simplifying 3D cell culture generation
  • How to automate organoid cultures workflows to reduce time and resources
  • Ensuring reproducible and standardized 3D cell cultures that can be scaled
  • High-throughput solutions offering full documentation for compliance

Agenda

  • JAN 23, 2024 12:00 PM EST

    Retaining Cell Viability and Morphology in IPSCs: Vital Tools for Research

    Daryl Cole
    Applications Scientist, Sartorius
    BIOGRAPHY
  • JAN 23, 2024 11:00 AM EST

    Maximizing the Potential of 3D Organoid Research with Automated Isolation

    Andris Abramenkovs
    Product Manager, CellCelector, Sartorius
    BIOGRAPHY
  • JAN 23, 2024 10:00 AM EST

    Exploring the Potential of 3D Organoids through Live-Cell Analysis

    Kalpana Barnes
    Manager, Cell Imaging Applications, Sartorius
    BIOGRAPHY
Help

Connect with us